# Relmada Therapeutics (RLMD) — Analyst Forecast

RLMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rlmd/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jun 18, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $12.00 |
| Mar 24, 2026 | Piper Sandler | Initiated Coverage | Overweight | $12.00 |
| Mar 20, 2026 | Mizuho | Maintained | Outperform | $19.00 |
| Mar 2, 2026 | LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $14.00 |
| Jan 23, 2026 | Leerink Partners | Upgraded | Market Perform → Outperform | $8.00 |
| Dec 22, 2025 | Jefferies | Initiated Coverage | Buy | $9.00 |
| Nov 19, 2025 | Mizuho | Upgraded | Neutral → Outperform | $10.00 |
| Dec 5, 2024 | Mizuho | Downgraded | Outperform → Neutral | $1.00 |
| Dec 4, 2024 | Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 |
| Sep 17, 2024 | Jefferies | Upgraded | Hold → Buy | $13.00 |
| Jun 5, 2024 | Goldman Sachs | Downgraded | Neutral → Sell | $2.00 |
| Jun 15, 2023 | Mizuho | Maintained | Buy | $26.00 |

## Frequently Asked Questions

### Is RLMD a buy, sell, or hold?

Analysts covering Relmada Therapeutics currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on RLMD?

On Jun 18, 2026, HC Wainwright & Co. initiated coverage of Relmada Therapeutics at Buy with a price target of $12.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).